External Beam Radiotherapy for Thyroid Cancer
Treatment of differentiated thyroid cancer (DTC) most often involves a combination of surgery, radioactive iodine (RAI) and suppression of thyroid-stimulating hormone (TSH). In specific situations, external beam radiotherapy (EBRT) could be of benefit, although this remains controversial because of a lack of randomized evidence to support its use. In contrast, EBRT is of standard use in the multimodal management of anaplastic thyroid cancer (ATC) with surgery and systemic agents. Despite this, outcomes remain poor, supporting the need for additional research of this devastating disease. This chapter focuses on the role of EBRT in DTC and ATC.
KeywordsThyroid Cancer Differentiate Thyroid Cancer Tracheal Stenosis Anaplastic Thyroid Cancer American Thyroid Association
- 8.American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.CrossRefGoogle Scholar
- 9.British Thyroid Association, Royal College of Physicians. Guidelines for the management of thyroid cancer. In: Perros P, editor. Report of the thyroid cancer guidelines update group. 2nd ed. London: Royal College of Physicians; 2007.Google Scholar
- 19.Wang Y, Tsang R, Asa S, et al. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens. Cancer. 2006;107:1786–92.Google Scholar